News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Baxter BioPharma Solutions' sterile manufacturing agreement with Novavax will help increase commercial production of the vaccine in Europe and the UK.
Swissmedic, the Swiss Agency for Therapeutic Products, has authorized Moderna’s COVID-19 vaccine for adults aged 18+.
UK biotech, OXGENE, says its SLIM platform for discovery of antibodies against membrane proteins in their native configuration in mammalian cells could support CAR-T therapeutics.
The European Commission had held discussions with French pharma company, Valneva, with a view to securing up to 60 million doses of its inactivated virus COVID-19 vaccine, VLA2001.